| Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis O Zusman, S Altunin, F Koppel, Y Dishon Benattar, H Gedik, M Paul Journal of Antimicrobial Chemotherapy 72 (1), 29-39, 2016 | 176 | 2016 |
| Money and transmission of bacteria H Gedik, TA Voss, A Voss Antimicrobial resistance and infection control 2, 1-4, 2013 | 108 | 2013 |
| Bloodstream infections in patients with hematological malignancies: which is more fatal–cancer or resistant pathogens? H Gedik, F Şimşek, A Kantürk, T Yildirmak, D Arica, D Aydin, N Demirel, ... Therapeutics and clinical risk management, 743-752, 2014 | 88 | 2014 |
| Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: monotherapy or combination therapy? F Şimşek, H Gedik, MT Yıldırmak, NE Iris, A Türkmen, A Ersoy, M Ersöz, ... Indian journal of medical microbiology 30 (4), 448-452, 2012 | 51 | 2012 |
| Etiological causes of pancytopenia: A report of 137 cases O Yokus, H Gedik Avicenna journal of medicine 6 (04), 109-112, 2016 | 33 | 2016 |
| The cost analysis of inpatients with COVID-19 H Gedik Acta Medica Mediterr 36 (1), 3289-3292, 2020 | 27 | 2020 |
| Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies H Gedik, T Yıldırmak, F Şimşek, A Kantürk, D Arıca, D Aydın, O Yokuş, ... The Journal of Infection in Developing Countries 8 (09), 1113-1118, 2014 | 22 | 2014 |
| Pulmonary involvement of Brucellosis: a report of six cases F Simsek, MT Yildirmak, H Gedik, A Kantürk, EN Iris African Health Sciences 11, 112-116, 2011 | 17 | 2011 |
| Extended-Spectrum β-Lactamase Production Rates of Klebsiella spp. and Escherichia coli Strains Isolated From Infections and Fecal Samples of Healthy People H Gedik, M Yahyaoglu, G Yörük, M Fincanc Infectious Diseases in Clinical Practice 18 (2), 104-106, 2010 | 15 | 2010 |
| Which multidrug-resitant bacteria are emerging in patients with hematological malignancies?: one-Year Report H Gedik, F Şimşek, T Yıldırmak, A Kantürk, D Aydın, N Demirel, O Yokuş, ... Indian Journal of Hematology and Blood Transfusion 31, 51-56, 2015 | 14 | 2015 |
| The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies DN Gedik H, Yildirmak T, Simsek F, Kanturk A, Aydın D African Health Sciences, 362-368, 2013 | 14 | 2013 |
| Antibiotic resistance status and its costs in hematological patients: A two-year analysis H Gedik Caspian journal of internal medicine 8 (4), 276, 2017 | 13 | 2017 |
| Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness G Habip, K Arzu, Y Taner, A Deniz, A Demet, Y Osman, D Naciye, ... African health sciences 14 (4), 899-905, 2014 | 13 | 2014 |
| The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis H Gedik ClinicoEconomics and Outcomes Research, 537-543, 2015 | 11 | 2015 |
| Community-acquired intracranial suppurative infections: a 15-year report T Yıldırmak, H Gedik, F Şimşek, A Kantürk Surgical Neurology International 5, 2014 | 11 | 2014 |
| Tuberculous meningitis: a report of 60 adult cases. M Ersöz, MT Yildirmak, H Gedik, F Şimşek, A Kantürk, NE Iris, E Dinç West indian medical journal 61 (6), 2012 | 11 | 2012 |
| Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing Enterobacteriaceae in cancer patients S Çeken, G Iskender, H Gedik, F Duygu, D Mert, AH Kaya, F Altuntas, ... The Journal of Infection in Developing Countries 12 (04), 265-272, 2018 | 10 | 2018 |
| Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage H Gedik, F Şimşek, T Yıldırmak, A Kantürk, D Arıca, D Aydın, N Demirel, ... Therapeutics and clinical risk management, 305-312, 2014 | 10 | 2014 |
| Evaluation of risk factors for mortality in febrile neutropenia S Çeken, H Gedik, G Iskender, M Demirelli, D Mert, GY Toros, ... The Journal of Infection in Developing Countries 14 (08), 886-892, 2020 | 7 | 2020 |
| Could neutrophil CD64 expression be used as a diagnostic parameter of bacteremia in patients with febrile neutropenia? NE Iris, T Yıldırmak, H Gedik, F Şimşek, D Aydın, N Demirel, O Yokuş Turkish Journal of Hematology 34 (2), 167, 2017 | 7 | 2017 |
Sabahat CekenSağlık Bilimleri ÜniversitesiEmail verificata su saglik.gov.tr
